These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 35273933)
1. Effectiveness of Interventions for Prevention of Common Infections Among Opioid Users: A Systematic Review of Systematic Reviews. Puzhko S; Eisenberg MJ; Filion KB; Windle SB; Hébert-Losier A; Gore G; Paraskevopoulos E; Martel MO; Kudrina I Front Public Health; 2022; 10():749033. PubMed ID: 35273933 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of interventions for prevention of common infections in people who use opioids: a protocol for a systematic review of systematic reviews. Kudrina I; Puzhko S; Filion KB; Gore G; Paraskevopoulos E; Windle S; Martel MO; Eisenberg MJ Syst Rev; 2021 Nov; 10(1):298. PubMed ID: 34782008 [TBL] [Abstract][Full Text] [Related]
3. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449 [TBL] [Abstract][Full Text] [Related]
4. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009 [TBL] [Abstract][Full Text] [Related]
5. Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020). Palmateer N; Hamill V; Bergenstrom A; Bloomfield H; Gordon L; Stone J; Fraser H; Seyler T; Duan Y; Tran R; Trayner K; Biggam C; Smith S; Vickerman P; Hickman M; Hutchinson S Int J Drug Policy; 2022 Nov; 109():103872. PubMed ID: 36202039 [TBL] [Abstract][Full Text] [Related]
6. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410 [TBL] [Abstract][Full Text] [Related]
7. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. van Santen DK; Lodi S; Dietze P; van den Boom W; Hayashi K; Dong H; Cui Z; Maher L; Hickman M; Boyd A; Prins M Addiction; 2023 Jun; 118(6):1116-1126. PubMed ID: 36710474 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews. Fernandes RM; Cary M; Duarte G; Jesus G; Alarcão J; Torre C; Costa S; Costa J; Carneiro AV BMC Public Health; 2017 Apr; 17(1):309. PubMed ID: 28399843 [TBL] [Abstract][Full Text] [Related]
10. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055 [TBL] [Abstract][Full Text] [Related]
12. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207 [TBL] [Abstract][Full Text] [Related]
13. Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky. Stone J; Fraser H; Young AM; Havens JR; Vickerman P Int J Drug Policy; 2021 Feb; 88():102707. PubMed ID: 32151496 [TBL] [Abstract][Full Text] [Related]
14. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. Des Jarlais DC; Feelemyer JP; Modi SN; Abdul-Quader A; Hagan H BMC Public Health; 2013 Jan; 13():53. PubMed ID: 23332005 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. Abdul-Quader AS; Feelemyer J; Modi S; Stein ES; Briceno A; Semaan S; Horvath T; Kennedy GE; Des Jarlais DC AIDS Behav; 2013 Nov; 17(9):2878-92. PubMed ID: 23975473 [TBL] [Abstract][Full Text] [Related]
16. Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya. Stone J; Fraser H; Walker JG; Mafirakureva N; Mundia B; Cleland C; Bartilol K; Musyoki H; Waruiru W; Ragi A; Bhattacharjee P; Chhun N; Lizcano J; Akiyama MJ; Cherutich P; Wisse E; Kurth A; Luhmann N; Vickerman P AIDS; 2022 Dec; 36(15):2191-2201. PubMed ID: 36111533 [TBL] [Abstract][Full Text] [Related]
17. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania. Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964 [TBL] [Abstract][Full Text] [Related]
18. Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping. Tonin FS; Alves da Costa F; Fernandez-Llimos F Addict Sci Clin Pract; 2024 Feb; 19(1):9. PubMed ID: 38310293 [TBL] [Abstract][Full Text] [Related]
19. Novel interventions to prevent HIV and HCV among persons who inject drugs. Coffin PO; Rowe C; Santos GM Curr HIV/AIDS Rep; 2015 Mar; 12(1):145-63. PubMed ID: 25589380 [TBL] [Abstract][Full Text] [Related]
20. An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. Perlman DC; Jordan AE; Uuskula A; Huong DT; Masson CL; Schackman BR; Des Jarlais DC Int J Drug Policy; 2015 Nov; 26(11):1056-63. PubMed ID: 26050614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]